f Decorated Lactoferrin-PEG-co-lactate - A Novel Pharmaceutical Excipient for Topical Delivery of Anti-cancer Therapeutics

References

1. LiuZ. JiangM. KangT. Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration.Biomaterials201334153870388110.1016/j.biomaterials.2013.02.003 23453061
   [Google Scholar]
2. Guzmán-MejíaF. Godínez-VictoriaM. Molotla-TorresD.E. Drago-SerranoM.E. Lactoferrin as a component of pharmaceutical preparations: An experimental focus.Pharmaceuticals (Basel)202316221410.3390/ph16020214 37259362
   [Google Scholar]
3. OngR. CornishJ. WenJ. Nanoparticular and other carriers to deliver lactoferrin for antimicrobial, antibiofilm and bone-regenerating effects: A review.Biometals202336370972710.1007/s10534‑022‑00455‑9 36512300
   [Google Scholar]
4. YaoX. BuntC. LiuM. Enhanced cellular uptake and transport of bovine lactoferrin using pectin- and chitosan-modified solid lipid nanoparticles.Pharmaceutics2023158216810.3390/pharmaceutics15082168 37631382
   [Google Scholar]
5. HuK. LiJ. ShenY. Lactoferrin-conjugated PEG–PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations.J. Control. Release20091341556110.1016/j.jconrel.2008.10.016 19038299
   [Google Scholar]
6. NojimaY. IguchiK. SuzukiY. SatoA. The pH-dependent formation of PEGylated bovine lactoferrin by branched polyethylene glycol (PEG)-N-hydroxysuccinimide (NHS) active esters.Biol. Pharm. Bull.200932352352610.1248/bpb.32.523 19252310
   [Google Scholar]
7. HongR. XieA. JiangC. A review of the biological activities of lactoferrin: Mechanisms and potential applications.Food Funct.202415168182819910.1039/D4FO02083A 39027924
   [Google Scholar]
8. NojimaY. SuzukiY. YoshidaK. Lactoferrin conjugated with 40-kDa branched poly(ethylene glycol) has an improved circulating half-life.Pharm. Res.20092692125213210.1007/s11095‑009‑9925‑z 19554429
   [Google Scholar]
9. LiuK. TongZ. ZhangX. Review: Development of a synthetic lactoferrin biological system.Biodesign Research2024p. 6
   [Google Scholar]
10. NojimaY. SuzukiY. IguchiK. Development of poly(ethylene glycol) conjugated lactoferrin for oral administration.Bioconjug. Chem.200819112253225910.1021/bc800258v 18834167
    [Google Scholar]
11. WeiM. GuoX. TuL. Lactoferrin-modified PEGylated liposomes loaded with doxorubicin for targeting delivery to hepatocellular carcinoma.Int. J. Nanomedicine20151051235137 26316745
    [Google Scholar]
12. ZiminaT. SitkovN. KarasevV. Design of peptide ligand for lactoferrin and study of its binding specificity.Chemosensors202311316210.3390/chemosensors11030162
    [Google Scholar]
13. GoyalK. KonarA. KumarB.S.H. KoulV. Lactoferrin-conjugated pH and redox-sensitive polymersomes based on PEG-S-S-PLA-PCL-OH boost delivery of bacosides to the brain.Nanoscale20181037177811779810.1039/C8NR03828G 30215650
    [Google Scholar]
14. YaoX. BuntC. CornishJ. QuekS.Y. WenJ. Oral delivery of lactoferrin: A review.Int. J. Pept. Res. Ther.201319212513410.1007/s10989‑012‑9326‑8
    [Google Scholar]
15. Varela-FernándezR. García-OteroX. Díaz-ToméV. Design, optimization, and characterization of lactoferrin-loaded chitosan/TPP and chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a pharmacological alternative for keratoconus treatment.ACS Appl. Mater. Interfaces20211333559357510.1021/acsami.0c18926 33428398
    [Google Scholar]
16. Varela-FernándezR. García-OteroX. Díaz-ToméV. Mucoadhesive PLGA nanospheres and nanocapsules for lactoferrin controlled ocular delivery.Pharmaceutics202214479910.3390/pharmaceutics14040799 35456633
    [Google Scholar]
17. LimL.Y. KohP.Y. SomaniS. Tumor regression following intravenous administration of lactoferrin- and lactoferricin-bearing dendriplexes.Nanomedicine20151161445145410.1016/j.nano.2015.04.006 25933695
    [Google Scholar]
18. OtsukiK. ImaiN. Effects of lactoferrin in 6 patients with refractory bacterial vaginosis.Biochem. Cell Biol.2017951313310.1139/bcb‑2016‑0051 28140620
    [Google Scholar]